Clinical Trials Browser

Phase 1/2 × Epstein-Barr Virus Infections × 30 days × Clear all

NCT04364178 2026-05-27

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Phase 1/2 Terminated

8 enrolled 14 charts

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT05164094 2026-05-06

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Phase 1/2 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections